News

3 Feb 2023

Huntington’s metabolic dysfunctions – PhD interview with Elna Dickson

Huntington's disease is known as the "dance disease" due to the patient's characteristic motor symptoms. However, Elna Dickson's Ph.D. project shows that the disease also leads to ...

13 Jan 2023

Cognitive disease beyond the brain – PhD interview with Keivan Javanshiri

Keivan Javanshiri’s Ph.D. project explores cardiac and vascular pathologies in Lewy body dementia and Alzheimer's disease. January 20, he defends his thesis. Here, he shares the mo...

12 Jan 2023

Nerve cells could transform the treatment of Parkinson’s

At the end of October 2022, the Swedish Medical Products Agency gave the go-ahead for a clinical trial of the stem cell-based therapy STEM-PD for the treatment of Parkinson’s disea...

10 Jan 2023

Why dopamine receptor type matters – PhD interview with Katrine Skovgård

Katrine Skovgård’s Ph.D. project sheds light on the dysfunctions in the brain through which dopaminergic pharmacotherapies for Parkinson’s disease affect motor behaviors. January 1...

3 Jan 2023

Optimal blood tests for development of new therapies of Alzheimer’s disease

A new study have identified which blood tests are best at detecting Alzheimer’s disease during the earliest stages, and also another blood test that is optimal for detecting releva...

21 Dec 2022

MultiPark – Closing the circle of 2022 and looking forward to 2023

We ended the MultiPark year in December as we started it in January: with a MultiPark Retreat! The December retreat was our first big meeting IRL after the pandemic, and it turned ...

14 Dec 2022

Molecular signaling in neurodegenerative disorders – A special interest group

MultiPark’s new special interest groups (SIGs) address essential scientific and technological needs and provide opportunities for professional development and network formation to ...

8 Dec 2022

Nobel Prize winner Arvid Carlsson – 7 things you perhaps did not know about him and his research